---
figid: PMC8088128__MCB.00627-20_f003
figtitle: 'Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function
  Perspective'
organisms:
- NA
pmcid: PMC8088128
filename: MCB.00627-20_f003.jpg
figlink: /pmc/articles/PMC8088128/figure/F3/
number: F3
caption: SHOC2-regulated RAS effector pathways and dynamic functional interactions.
  Shown is a schematic pathway overview of SHOC2’s role in the MAPK/ERK pathway involving
  MRAS/PP1 holophosphatase complex (A), HUWE1/PSMC5/VCP (B), interactors that sequester
  SHOC2 from RAS (C), posttranslational modifications that result in SHOC2 degradation
  (D), and PIK3CA/p110α that mediates PI3K/AKT signaling (E). Direct SHOC2 interactors
  that result in diminished MAPK signaling are depicted in red, and those that enable
  MAPK signaling are in blue. Ubiquitin chains are represented in purple, and multivesicular
  bodies (MVB)/late endosome (LE) are indicated.
papertitle: 'A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function
  Perspective.'
reftext: Jason J. Kwon, et al. Mol Cell Biol. 2021 Apr;41(4):e00627-20.
year: '2021'
doi: 10.1128/MCB.00627-20
journal_title: Molecular and Cellular Biology
journal_nlm_ta: Mol Cell Biol
publisher_name: American Society for Microbiology
keywords: cancer | leucine-rich repeat | MAPK signaling | Noonan syndrome | PP1C |
  RAF | RAS | receptor tyrosine kinase | SHOC2
automl_pathway: 0.9416929
figid_alias: PMC8088128__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8088128__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8088128__MCB.00627-20_f003.html
  '@type': Dataset
  description: SHOC2-regulated RAS effector pathways and dynamic functional interactions.
    Shown is a schematic pathway overview of SHOC2’s role in the MAPK/ERK pathway
    involving MRAS/PP1 holophosphatase complex (A), HUWE1/PSMC5/VCP (B), interactors
    that sequester SHOC2 from RAS (C), posttranslational modifications that result
    in SHOC2 degradation (D), and PIK3CA/p110α that mediates PI3K/AKT signaling (E).
    Direct SHOC2 interactors that result in diminished MAPK signaling are depicted
    in red, and those that enable MAPK signaling are in blue. Ubiquitin chains are
    represented in purple, and multivesicular bodies (MVB)/late endosome (LE) are
    indicated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MRAS
  - SHOC2
  - SCRIB
  - PPA1
  - NPY4R
  - NPY4R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - ERBIN
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - RPTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - PIK3CA
  - AKT1
  - AKT2
  - AKT3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - VCP
  - PSMC5
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - RNASE3
  - HUWE1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - FBXW7
---
